吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Aug 3 2018

Full Issue

Perspectives: Therapy For Opioid Use Needs To Begin In Correctional Facilities; Epidemic Stunting Ohio's Economy

Editorial pages focus on the opioid crisis.

Every year, 1 in 3 of the 2 million people with opioid use disorder in the United States is arrested. It follows that correctional facilities, that is, detention centers, jails, and prisons, have important roles in engaging people with opioid use disorder in effective treatment. Opioid agonist therapy with methadone hydrochloride, a full opioid agonist, or buprenorphine hydrochloride, a partial agonist, effectively treats opioid use disorder and reduces mortality. There is no comparable evidence for reduced mortality with naltrexone hydrochloride, an extended-release, full opioid antagonist also approved by the US Food and Drug Administration for treatment of opioid use disorder. Yet opioid agonist treatment is used infrequently in correctional facilities. What steps must be taken to change the situation? (Kevin Fiscella, Sarah E. Wakeman and Leo Beletsky, 7/30)

Our economy is growing and businesses are expanding and looking for workers. Go on聽Ohiomeansjobs.com today and you will see more than 140,000 jobs advertised. Businesses say pro-growth federal policies -- tax reform especially -- are helping them grow and increasing optimism about the future. Since the first of the year, I've visited 21 businesses across Ohio that have raised wages, delivered bonuses, bought new equipment, increased workers' benefits and more as a direct result of tax reform. At another dozen small-business roundtable discussions, I have heard the same story. Despite all these job openings in Ohio, we still have a historically high number of people out of the workforce altogether. I believe it is because the opioid epidemic gripping our state has depleted the pool of workers and stunted our full economic potential. (Sen. Rob Portman, 8/2)

Maryland has just issued its latest report on the opioid epidemic in the state; let鈥檚 start by recounting the good news, because, unfortunately, it won鈥檛 take long. Overdose deaths related to heroin declined from 1,212 in 2016 to 1,078 in 2017; deaths in which prescription opioids were involved also fell slightly, from 418 to 413. Data from other sources indicate that opioid prescribing is waning. Such statistics suggest the state is finally making headway against those two killers. Nevertheless, overall deaths due to drug and alcohol intoxication rose by 9 percent, to a record 2,282. This was the seventh straight annual increase and probably means that Maryland still has one of the top five death rates among the states for opioid-related overdoses, as it did in 2016, according to the National Institute on Drug Abuse. (8/2)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, August 6
  • Wednesday, August 5
  • Tuesday, August 4
  • Monday, August 3
  • Friday, July 31
  • Thursday, July 30
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF